ECRIN has published the July 2019 edition of its newsletter.
The EU-CELAC working group on Research Infrastructures was created within the framework of the EU-CELAC Joint Initiative on Research and Innovation, with the purpose of sharing insight on research infrastructures in Europe and Latin American and Caribbean countries.
In Madrid – November 7-8, 2019
The first edition of the EULAC PerMed ‘Summer School’, organised by the EULAC PerMed consortium in collaboration with the Instituto de Salud Carlos III (ISCIII), will be held in Madrid, Spain from November 7 to 8, 2019.
ECRIN is proud to announce that it has now published its 2018 annual report.
ECRIN participated in the EURORDIS Summer School from 10 to 14 June 2019 in Barcelona, Spain.
ECRIN has now launched the 2019 call for its Data Centre Certification programme.
This programme identifies non-commercial clinical trials units (CTUs) in Europe that have demonstrated they can provide safe, secure, compliant and efficient management of clinical research data.
EU-OPENSCREEN-DRIVE is offering funding for chemoproteomics and small molecule screen projects.
5th Call for TRANSVAC2 Training Modules
M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing
Venue: Fraunhofer IME, Aachen Germany
Dates: 10-11 October 2019
FAIR PARK II (Conservative Iron Chelation as a Disease-Modifying Strategy in Parkinson's Disease), an ECRIN-supported clinical trial, has released its June 2019 newsletter.
The EULAC PerMed (Widening EU-CELAC policy and research cooperation in Personalised Medicine) project website is now online.
The Slovak International Clinical Trials Day (ICTD) 2019 took place on May 30th, 2019 in Bratislava with the participation of ECRIN's Director General, Jacques Demotes, and leaders of national infrastructures within V4 countries, i.e.
Health Research Board Clinical Research Coordination Ireland (HRB CRCI) hosted a conference to celebrate International Clinical Trials Day (ICTD) 2019.
The ECRAID-plan Consortium and Working Group meeting took place from May 20-21st in Amsterdam. The objectives of the consortium meeting were to:
Press Release: International Clinical Trials Day 2019: Patient stratification studies: challenges and opportunities
Press Release – Paris, May 2019.
In April 2019 TRANSVAC2 launched a fourth call for Training Modules (M6, M7 and M9) offered by the TRANSVAC2 project. The deadline has been extended to 1 June 2019. For more information, see below:
The PedCRIN funded WE Study (Walking Easier with cerebral palsy) is a double blind placebo controlled randomized trial in children between 4-17 years.